Stay updated on Psilocybin Bioavailability in Adult Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Bioavailability in Adult Clinical Trial page.

Latest updates to the Psilocybin Bioavailability in Adult Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA sitewide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434; the study record itself remains an error page.SummaryDifference1%

- Check18 days agoChange DetectedThe footer’s site revision changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check25 days agoChange DetectedThe error page’s footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedThe Study Record page now shows a 403 Forbidden error, replacing the usual study details with an access-denied message. The surrounding layout remains, but users cannot access the study content from this page.SummaryDifference17%

- Check67 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a metadata update to the ClinicalTrials.gov record. This reflects a minor version change rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Psilocybin Bioavailability in Adult Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Bioavailability in Adult Clinical Trial page.